Grantham, Mayo, Van Otterloo & Co (GMO)
CVET

Grantham, Mayo, Van Otterloo & Co (GMO)’s Covetrus, Inc. Common Stock CVET Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,100
Closed -$606K – 972
2020
Q4 		$606K Buy
21,100
+5,400
+34% +$146K ﹤0.01% 651
2020
Q3 		$383K Sell
15,700
-63,900
-80% -$1.38M ﹤0.01% 659
2020
Q2 		$1.42M Buy
+79,600
New +$1.05M 0.01% 471

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCM
Freshford Capital Management Rye Brook, New York $200M AUM 31.49% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CVET Position: Q1 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Covetrus, Inc. Common Stock (CVET) in Q1 2021, closing a stake of 21,100 shares — an estimated $606K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CVET in Q2 2020 and held it in 3 quarters. The position peaked at $1.42M in Q2 2020. 273 funds tracked by Wall St. Rank hold CVET as of Q1 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Covetrus, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 21,100 Covetrus, Inc. Common Stock shares in Q1 2021, an estimated $606K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Covetrus, Inc. Common Stock in Q2 2020 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Covetrus, Inc. Common Stock position peaked at $1.42M in Q2 2020.
  • 273 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q1 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2021, filed 13 May 2021.